GlassScriptPhysician profile
Ene Grace Morgan
NPI 1821651951
$775.77
in general payments reported to CMS, 2019-2025
14 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $67.42 · 2024: $455 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $127.00 | 2024-2025 | Veozah |
| Caldera Medical, INC | $106.20 | 2024 | Desara |
| Mayne Pharma Commercial LLC | $102.44 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.26 | 2024-2025 | |
| Pfizer INC. | $70.06 | 2023-2025 | |
| Optumhealth Care Solutions, LLC | $67.24 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Shield Therapeutics INC | $51.96 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $47.41 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $38.12 | 2024-2025 | Fluent Fluid Management System, Acessa Provu System |
| Lsi Solutions INC | $29.43 | 2024 | Fornisee |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.97 | 2024 | Xifaxan |
| Davol INC. | $18.86 | 2024 | Arista Ah Flexitip |
| Abbvie INC. | $13.92 | 2025 | |
| Intuitive Surgical, INC. | $5.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ene Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.